Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Chemistryselect|January 31, 2023
Alcohol-based Hand Sanitizers amid COVID-19: Chemical Formulation, Analysis, SafetyMonarul Islam, Khondoker Shahin Ahmed, Rezaul Karim, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 2, 2024
Patient Characteristics Associated With Disparities in Engagement With and Experience of COVID-19 Remote Home Monitoring Services: A Mixed-Methods EvaluationNadia E Crellin, Lauren Herlitz, Manbinder S Sidhu, et al.
Health and Social Care Delivery Research|October 6, 2023
A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in EnglandNaomi J Fulop, Holly Walton, Nadia Crellin, et al.
The Lancet. Infectious Diseases|October 10, 2021
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy studyAdam Penn-Nicholson, Sophia B Georghiou, Nelly Ciobanu, et al.
Microbiology Spectrum|July 28, 2021
A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell CultureAhmed K Oraby, Cassandra L Gardner, Robert F Needle, et al.
The Journal of Infectious Diseases|October 9, 2019
Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility TestsSophia B Georghiou, Samuel G Schumacher, Timothy C Rodwell, et al.
Journal of Clinical Microbiology|May 27, 2016
Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept StudyRebecca E Colman, Julia Anderson, Darrin Lemmer, et al.
Diagnostic Microbiology and Infectious Disease|June 15, 2021
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detectionSophia B Georghiou, Adam Penn-Nicholson, Margaretha de Vos, et al.
Genes|October 29, 2025
Investigating the "Dark" Genome: First Report of Partington Syndrome in CyprusConstantia Aristidou, Athina Theodosiou, Pavlos Antoniou, et al.
The Lancet. Infectious Diseases|November 1, 2024
Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflowsRebecca E Colman, Marva Seifert, Andres De la Rossa, et al.
Pageof 28